Company : Novo, Global Business Services, India
Department : Centralised Monitoring Unit, Research & Development
Location : Bangalore, India
Does your motivation come from challenges and working in a dynamic environment? Do you thrive where close collaboration with key stakeholders and strategic alignment is essential? Do you have a can-do attitude with continuous improvement as one of your career objectives? Then we might have the right position for you. Apply now and join a growing team, working in an international environment.
As Dose Surveillance Advisor, you will help make sure people taking part in global clinical trials receive the dose their protocol prescribes. You will spot differences between prescribed and expected doses early, follow them up with trial teams and sites, and keep records inspection-ready. As this function evolves, you will also help shape how dose surveillance works. Your work protects patient safety and data quality, so trials deliver evidence that people living with serious chronic diseases can rely on.
Your day-to-day tasks will include:
You will keep a clear, data-driven view of dose compliance across your assigned trial sites and make sure issues are resolved quickly and traceably.
You will join the Centralised Monitoring Unit in Bangalore, part of Research & Development, where colleagues use data, technology and collaboration to move clinical development forward. Established alongside Novo Nordisk’s move to Risk-Based Monitoring in 2016 – now Risk-Based Quality Management (RBQM) – CMU helps identify, assess and reduce risks to clinical data and patient safety early, focusing on critical data, critical processes and key risks across the portfolio.
Your team brings together medical reviewers, central monitors, statistical monitors and functional programmers. Day to day, you will partner with Clinical Medical Managers, Retention Specialists, Medical Advisors, Trial Managers and trial squads, as well as trial sites. CMU also works closely with the RBQM office in Denmark and global trial teams, so your insights will reach studies and colleagues across countries and help them act on issues before they grow.
You combine clinical understanding with an eye for detail in data, and you are comfortable working with colleagues and sites around the world. You will bring:
You will work across diverse studies with international stakeholders and modern digital tools, building skills in data-driven monitoring and global clinical operations. As the dose surveillance function is still taking shape, your voice matters: you will be trusted to take ownership, share ideas and help define how the work is done.
You will be part of a team where quality and patient safety are never compromised, and where colleagues support each other to learn, improve and perform at their best.
There is, of course, more on offer here than the uniqueness of our culture and the extraordinary results we produce. Being part of a global healthcare company means opportunities to learn and develop are all around us, while our benefits are designed with your career and life stage in mind.
20 October 2026.
We commit to an inclusive recruitment process and equality of opportunity for all our job applicants.

We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health.
Our unordinary mindset is at the heart of everything we do. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 77,000 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com.
This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to remove those that are off-topic, abusive or intended to spam.
Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in:
https://www.novonordisk.com/contact-us/find-local-information.html
For other customer complaints, please contact us here:
https://www.novonordisk.com/contact-us.html
Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed.
Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users.
Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html